We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Thursday was a great session to extend this breakout rally above 2450. At first it seemed that investors wanted to take profits with red arrows flashing on the screen. Yet coming down the stretch the market rallied back to break even.
That is prototypical breakout behavior. Where pullbacks are fleeting mirages that disappear quickly as investors buy every dip for the fear of missing out on the next leg higher.
Keep hitting the buy button on the market as this bull market continues. A rotation to small caps is likely in order as well since large caps have had too much time in the sun. That is why I just picked up the 3X Smallcap ETF (TNA) to bolster my portfolio for the push to 2500.
Best,
Steve Reitmeister
Executive Vice President, Zacks Investment Research
We are approaching what could be one of the most exciting growth opportunity of the year. A new medical innovation has the potential to impact people all around the world.
Zacks recently launched an initiative to capitalize on this breakthrough. You?re invited to see these picks along with a special report about a soon-to-triple niche in the healthcare sector. Don't delay: this special opportunity ends at midnight Saturday, July 22.
Follow your investments easily in one place. Get free email updates that alert you to major events affecting your stocks and funds, including timely recommendation changes, earnings announcements and, most importantly, earnings estimate revisions.